13F HOLDINGS REPORT
BML Capital Management, LLC
Quarter ended Q4 2024 · Filed February 7, 2025 · Accession 0001754960-25-000111
Total Value
$161.0M
Positions
25
Other Managers
0
Confidential Omitted
No
Holdings (25)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ACLARIS THERAPEUTICS INC | ACRS | 14,250,000 | $35.3M | 21.95% |
| 2 | ISHARES TR | 46436E718 | 260,000 | $26.1M | 16.20% |
| 3 | ATEA PHARMACEUTICALS INC | AVIR | 7,608,312 | $25.5M | 15.83% |
| 4 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 2,268,064 | $10.6M | 6.58% |
| 5 | AN2 THERAPEUTICS INC | ANTX | 5,749,432 | $7.9M | 4.93% |
| 6 | INSTIL BIO INC | TIL | 400,000 | $7.6M | 4.74% |
| 7 | ESSA PHARMA INC | 29668H708 | 4,221,546 | $7.6M | 4.69% |
| 8 | AADI BIOSCIENCE INC | WHWK | 2,100,000 | $6.6M | 4.12% |
| 9 | ORAMED PHARMACEUTICALS INC | ORMP | 2,643,907 | $6.4M | 3.97% |
| 10 | IKENA ONCOLOGY INC | 45175G108 | 3,585,866 | $5.9M | 3.65% |
| 11 | PMV PHARMACEUTICALS INC | PMVP | 3,466,684 | $5.2M | 3.25% |
| 12 | ACHILLES THERAPEUTICS PLC | 00449L102 | 4,100,002 | $4.7M | 2.90% |
| 13 | CONNECT BIOPHARMA HLDGS LTD | CNTB | 2,093,232 | $2.9M | 1.79% |
| 14 | MILESTONE PHARMACEUTICALS IN | MIST | 1,136,091 | $2.7M | 1.67% |
| 15 | ATHIRA PHARMA INC | 04746L104 | 2,775,885 | $1.6M | 1.01% |
| 16 | ASTROTECH CORP | ASTC | 220,410 | $1.5M | 0.92% |
| 17 | LISATA THERAPEUTICS INC | LSTA | 284,669 | $848,314 | 0.53% |
| 18 | PALVELLA THERAPEUTICS INC NE | PVLA | 42,130 | $505,560 | 0.31% |
| 19 | VISTAGEN THERAPEUTICS INC | VTGN | 150,000 | $442,500 | 0.27% |
| 20 | KEZAR LIFE SCIENCES INC | KZR | 48,668 | $327,049 | 0.20% |
| 21 | LENZ THERAPEUTICS INC | LENZ | 9,271 | $267,654 | 0.17% |
| 22 | NEXTCURE INC | NXTC | 273,536 | $210,896 | 0.13% |
| 23 | VERRICA PHARMACEUTICALS INC | VRCA | 174,651 | $122,256 | 0.08% |
| 24 | ALLOVIR INC | 019818103 | 184,246 | $77,383 | 0.05% |
| 25 | HILLEVAX INC | 43157M102 | 20,760 | $42,973 | 0.03% |